PHARMACOLOGY OF ETROLIZUMAB IN A PHASE 2 STUDY IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Caroline Looney  1     Franklin Fuh  1     Meina Tang  1     Xiaohui Wei  1     Mary E. Keir  1     Gaik Tew  1     Jeffrey Eastham-Anderson  2     Lauri Diehl     Azucena Salas     Gert De Hertogh     Steven Francom     Houston Gilbert     Diana Luca     Jackson Egan     Severine Vermeire     John Charles Mansfield     Christopher Andrew Lamb     Brian G. Feagan     Julian Panés     Daniel C. Bau    
1 Genentech, Inc., South San Francisco, United States
2 Genentech,

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing